• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Microbot advances Liberty robotic system to next phase of remote telesurgery evaluation

cafead

Administrator
Staff member
  • cafead   Aug 25, 2024 at 11:12: PM
via Microbot’s Liberty system is also being evaluated in an IDE study as the company aims to join the billion-dollar surgical robotics market.

article source